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.2012.08.Abstract Background: Total intravenous anesthesia (TIVA) versus inhalational anesthesia was
selected as the anesthetic method, in order to avoid the use of muscle relaxants during repair of bra-
chial plexus injury. We designed this study to determine effect and efﬁcacy of TIVA versus sevoﬂu-
rane during repair of brachial plexus injury.
Methods: Sixty patients scheduled for repair of injured brachial plexus from January 2009 till
December 2011 were enrolled in this prospective, single-blind, randomized study. They received
either inhalation induction with sevoﬂurane and maintenance with sevoﬂurane and fentanyl
(Group 1) or TIVA with, propofol and fentanyl (Group 2) or TIVA with dexmedetomidine and
fentanyl (Group 3). Hemodynamics, intubation conditions, sedation score were assessed. Postop-
erative pain using visual analogue scale (VAS) was assessed. Discharge time, postoperative respi-
ratory condition, any postoperative complications were recorded.
Results: All groups provided a similar signiﬁcant reduction in hemodynamics compared with base-
line values. Respiratory rate values of dexmedetomidine–fentanyl group were signiﬁcantly highersthesia and Surgical Intensive
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32 S.A. Mousa, H. Abd Elfatah Alsobkythan those in other groups. Oxygen saturation values of dexmedetomidine–fentanyl group were sig-
niﬁcantly higher than those of propofol–fentanyl group. Time to reach an Aldrete score of 10 was
similar in all groups. Patients in sevoﬂurane–fentanyl group have signiﬁcantly higher visual ana-
logue score than other groups. Sedation score was higher in the dexmedetomidine–fentanyl group.
Conclusion: TIVA with propofol and with dexmedetomidine was more effective and favorable
anesthesia than sevoﬂurane anesthesia during repair of brachial plexus injury.
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Brachial plexus lesions are a tragic condition that usually af-
fects young adults, with signiﬁcant socioeconomic implications
[1]. The reported incidence of peripheral nerve injury among
the trauma population was 2% and it was 5% if plexus and
root lesions were included [2]. Closed traction is the most com-
mon mechanism in adults, which is mainly caused by high-en-
ergy forces such as motorcycle accident, and trauma leads to
section, contusion and/or stretch injuries of the neural ele-
ments. In addition, cervical nerve roots are frequently injured
or avulsed close to or from the spinal cord [3].
Prevention of postoperative neurological deﬁcits is a major
concern of the neurosurgeons and has led to the increased need
to use intra operative neurophysiologic monitoring. Among
these monitoring, intra operative direct nerve stimulation
had became popular. In our hospital, the neurosurgeons call
for anesthesia without the use of neuromuscular blockers dur-
ing repair of the brachial plexus injury. Direct nerve stimula-
tion was used for detection of motor nerves as well as to
distinguish the nerve from the surrounding tissues in a surgical
situation of disturbed anatomy with brachial plexus trauma.
Pain resolution should be the ﬁrst priority, and root explora-
tion and grafting helped to decrease or eliminate pain com-
plaints within a short time of surgery.
Regional anesthesia is associated with multiple beneﬁts
compared to general anesthesia, including decreased morbidity
and mortality [4,5], superior postoperative analgesia [6] and
enhanced cost effectiveness [7]. However, general anesthesia
still the most common used anesthetic technique for the repair
of brachial plexus injury in our locality. This might be assumed
to the medico legal aspect and involving the regional anesthe-
sia as a cause of neurological injury postoperatively.
Dexmedetomidine (Precedex), a pharmacologically active
dextroisomer of medetomidine, is a selective a2-adrenergic
receptor agonist which may be a useful adjuvant during gen-
eral anesthesia by promoting hemodynamic stability [8] and
decreasing the doses of anesthetics and analgesics [9,10]. Little
studies have been discussed the use of dexmedetomidine as an
adjuvant for anesthesia without muscle relaxants. The purpose
of this study was to compare the effect and the efﬁcacy of dex-
medetomidine as well as propofol total intra venous anesthesia
without muscle relaxant with sevoﬂurane anesthesia in patients
undergoing repair of brachial plexus injury.
2. Patients and methods
After obtaining approval of the hospital ethics committee and
written informed consent, we recruited 60 patients, with Amer-
ican Society of Anesthesiologists (ASA) grades I and II, anddiagnosed with brachial plexus injury, into the study from Jan-
uary 2009 till December 2011. All patients were scheduled for
exploration of brachial plexus at Mansoura University Hospi-
tal under general anesthesia to participate in the current pro-
spective, randomized study. Those with American Society of
Anesthesiologists grade III or higher, bronchial asthma, antic-
ipated difﬁcult airway, and a history of allergy to opioids or to
one of the used medications were excluded from the study.
All patients were thoroughly assessed preoperatively by his-
tory, physical examination and laboratory evaluations (com-
plete blood picture, liver function and renal function tests).
All patients were made familiar with the use of 10 cm a vi-
sual analogue scale score (VAS) identifying 0 as no pain and
10 as the worst imaginable pain. All patients received 10 mg
diazepam orally at the night of surgery. On arrival of the
patients to theater suite, and after routine monitoring, periph-
eral intravenous cannula (18G) was inserted on the contra
lateral forearm. Lactated Ringer’s solution was infused at a rate
of 8 ml/kg to replenish the overnight fasting hours. All patients
were premedicated with fentanyl 1.5 lg/kg (Fentanyl,
Janssen-Cilag, Germany) and midazolam 0.05 mg/kg
(Dormicum, Roche, Grenzach-Wyhlen, Germany).
In this single-blinded prospective study, the patients were
randomly allocated to one of three groups by use of sealed
envelopes (20 patients each). Group I (n= 20) received sevo-
ﬂurane–oxygen for induction and sevoﬂurane with fentanyl
infusion for maintenance of anesthesia. Group II (n= 20) re-
ceived propofol for induction followed by propofol–fentanyl
(Diprivan, Astra Zeneca, Wedel, Germany) for maintenance.
Group III (n= 20) received dexmedetomidine (Precedex,
Dexmedetomidine HCl inj., Hospira, Inc., Lacke Forest,
USA) for induction followed by dexmedetomidine–fentanyl
for maintenance. All anesthetics were prepared and adminis-
tered by an investigator not included in the study.
Induction of anesthesia in the sevoﬂurane group (GI) (via
an Abbot vaporizer) using a face mask with sevoﬂurane in a
circle system beginning with 8% with initial fresh gas ﬂow
(FGF) 6 l min1 of oxygen in air 50% decreasing to a total
FGF of 3 l min1 of oxygen in air 50% during maintenance
with 3% sevoﬂurane plus fentanyl infusion in a dose of
0.5 lg kg1 h1.
Induction of anesthesia in propofol–fentanyl group (GII)
was done by 1.5 mg kg1 propofol. The patients of this group
received a constant infusion of 2 mg kg1 h1 propofol and a
constant infusion of 0.5 lg kg1 h1 fentanyl.
In dexmedetomidine–fentanyl group (GIII), dexmedetomi-
dine was prepared by diluting 2 ml of dexmedetomidine am-
poule (100 lg ml1) with 48 ml of normal saline to a
concentration of 4 lg mll. Syringe containing aqueous solu-
tions of dexmedetomidine was prepared in a blind fashion by
a team member who was not involved in data recording. A sin-
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over 10 min using a syringe pump (Life Care 5000, Abbot)
and followed by a continuous infusion of dexmedetomidine
0.6 lg kg1 h1 plus fentanyl infusion in a dose of 0.5 lg kg
1 h1.
Anesthetist blindly participated as the intubator for all pa-
tients in the three groups by direct laryngoscopy with a Mac-
intosh blade3. Size 7.5 or 8.0 endotracheal tubes were used
in female and male patients respectively. Degree of jaw relax-
ation, vocal cord position, and intubating responses were used
for assessment of intubating conditions.
Jaw relaxation was described as fully relaxed (score = 1),
mildly resistant (score = 2), tight but open (score = 3), and
impossible (score = 4). Vocal cord position was described as
widely open (score = 1), midposition (score = 2), moving
but open (score = 3), and closed (score = 4). Intubating re-
sponses were described as none (score = 1), diaphragmatic
movement (score = 2), mild/moderate coughing (score = 3),
and severe coughing (score = 4). Intubating conditions were
graded as excellent (total score [TS] = 3), good (TS = 4–6),
poor (TS = 7–9), or impossible (TS = 10–12). If intubation
was impossible, succinylcholine was administered to facilitate
endotracheal intubation. The total score of 6 or less was clas-
siﬁed as an acceptable intubation condition otherwise as unac-
ceptable condition.
After successful intubation, controlled ventilation was
achieved by (Drager-model Fabius GS-Germany) ventilator
with tidal volume of 8–10 ml/kg and I/E ratio 1:2 to maintain
end tidal carbon dioxide tension around 35 mmHg.
General anesthesia was tailored to allow intraoperative di-
rect nerve stimulation to guide the localization and repair of
the injured nerves. Consequently, muscle relaxants were
avoided. The tissues suspected to be of nervous structure were
stimulated during the surgery by the operator using bipolar
stimulator (straight bipolar stimulating probe, Medtronic
The NIM 3.0-522 010 Micro fork probe) and motor re-
sponses were observed by the surgeon. The stimulus duration
was 0.1 ms and the maximum stimulus intensity was 5 mA.
ECG, non invasive blood pressure, pulse oximetry and end
tidal carbon dioxide (EtCO2) were monitored throughout sur-Table 1 Patients characteristics and duration of surgery (min). Val
GI (n= 20)
n
ASA I 15
II 5
Sex M 16
F 4
Age (years) 30.60 ± 4.09
Height (cm) 166.55 ± 6.27
Wt (kg) 75.75 ± 7.65
BMI 27.41 ± 3.45
Duration of surgery (min) 220.65 ± 14.65
Time to reach an Aldrete score of 10(min) 40.63 ± 5.44
Type of injury
N. avulsion 9
N. ruptured 7
N. stretched 4
GI = Sevoﬂurane–fentanyl group, GII = propofol–fentanyl group, GIIIgery by (Datex-Omeda model (S/5) AN. S. No: 3422715, Fin-
land, 1998) monitor.
Heart rate (HR), mean blood pressure (MBP), pulse oxim-
etry and EtCO2 were monitored as preoperative (basal), 5 min,
30 min, 1, 2, 3, 4 h postinduction, then 1 h postoperatively.
After surgery, extubation was performed and patients were
transferred to the postanesthesia care unit (PACU).
In the recovery area, modiﬁed Aldrete’s score was recorded
every 10 min until discharge. When patients attained score of
10, they considered ready for discharge (Table 5) [11].
Postoperative pain was assessed over 24 h using 10-cm vi-
sual analogue scale (VAS) where 0 = no pain and
10 = unbearable pain. VAS was recorded at times (early post-
operative, 15 min, 30 min, 1 h, 2, 4, 6, 12, 18, and 24 h). When
the patients experienced pain (VASP 4), they received rescue
dose of nalbuphine hydrochloride.
Any postoperative events like nausea, vomiting, shivering
or respiratory distress were recorded.
The statistical analysis of data was done by using excel pro-
gram for ﬁgures and SPSS (SPSS, Inc., Chicago, IL) program
statistical package for social science version 16.
To test the normality of data distribution K–S (Kolmogo-
rov–Smirnov) test was done only signiﬁcant data revealed to
be nonparametric. N.B: all tested data revealed to be paramet-
ric. The description of the data done in form of mean (±) SD
for quantitative data and frequency and proportion for Qual-
itative data.
The analysis of the data was done to test statistical signiﬁ-
cant difference between groups.
Chi square test was used for qualitative data. Any differ-
ence or change showing probability (P) less than 0.05 was con-
sidered statistically signiﬁcant at conﬁdence interval 95%.
A sample size of 20 patients in each group was calculated to
have 80% power with a Type II error of 0.8 with a= 0.05
using (G Power Analysis Program, version 3) in order to detect
an incidence of difﬁcult intubation of 25% of cases with a rel-
ative 20% change as being clinically signiﬁcant between the
two groups. These numbers are selected with the assumption
that dexmedetomidine has the same effect as that in our pilotues are presented as mean ± SD, number and %.
GII (n= 20) GIII (n= 20) P value
% n % n %
75 16 80 16 80
25 4 20 4 20 0.90
80 16 80 17 85 0.89
20 4 20 3 15
32.45 ± 4.34 32.00 ± 3.50 0.32
164.25 ± 6.32 162.10 ± 5.92 0.08
73.95 ± 7.91 72.50 ± 8.93 0.45
27.42 ± 2.67 27.77 ± 4.48 0.93
213.85 ± 20.30 216.45 ± 20.74 0.51
37.55 ± 8.60 40.53 ± 8.80 0.079
9 9
7 7 1.00
4 4
= dexmedetomidine–fentanyl group.
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Figure 1 (A) HR of the studied groups (beat/min) (B) MBP of the studied groups (mmHg). \Statistically signiﬁcant compared to the
baseline value.
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few cases at our institution.3. Results
There were no signiﬁcant differences among the groups for
age, sex distribution, body weight, height, BMI, the duration
of surgery, and 47 of patients were ranked as ASA I while
13 were ASA II. 9 patients with nerve avulsion, 7 patients with
nerve ruptured and 4 patients with nerve stretched were oper-
ated in each group (Table 1).
The time to reach a modiﬁed Aldrete’ score of 10 displayed
no signiﬁcant difference between the studied groups
((P< 0.079) (Table 1).
Heart rate showed no signiﬁcant changes among the three
studied group. In the three groups, there were similar signiﬁ-
cant reduction in HR and MBP compared with the basal val-
ues (P< 0.05) (Fig. 1A and B).At 1 h postoperative, there was a similar signiﬁcant increase
of both HR and MBP returning towards the normal baseline
(Fig. 1A and B).
Arterial oxygen saturation (SPO2) showed signiﬁcant in-
crease starting from 30 min. till 4 h postinduction reading in
sevoﬂurane–fentanyl and dexmedetomidine–fentanyl groups
compared with basal values. In comparison to propofol–
fentanyl group, dexmedetomidine–fentanyl group showed sig-
niﬁcant differences in SPO2 at 1 h, 3 h and 4 h being higher in
the latter group (Table 2).
Sevoﬂurane–fentanyl and propofol–fentanyl groups
showed signiﬁcant decrease in EtCO2 at 1, 2, 3 and 4 h postin-
duction compared with basal values, while signiﬁcant decrease
displayed only at 30 min, 1 h, 2 h postinduction in dexmede-
tomidine–fentanyl group. EtCO2 was signiﬁcantly higher in
propofol–fentanyl group compared with dexmedetomidine–
fentanyl group at 30 min. However, EtCO2 was within the nor-
Table 2 Arterial oxygen saturation (SPO2%) and end tidal carbon dioxide EtCO2 (mmHg) of the studied groups. Values are
mean ± SD.
SPO2 EtCO2
GI GII GIII GI GII GIII
Preoperative 98 ± 1 98 ± 1 98 ± 1 34 ± 5 37 ± 5 34 ± 5
Postinduc.
5 min 98 ± 2 98 ± 2 99 ± 1 35 ± 4 35 ± 6 32 ± 4
30 min 99 ± 1 98 ± 1 99 ± 1 32 ± 3 34 ± 5 30 ± 4.’’
1 h 99 ± 1 98 ± 2 99 ± 1.’’ 31 ± 3 33 ± 6 30 ± 4
2 h 99 ± 2 98 ± 2 99 ± 1 30 ± 4 33 ± 6 30 ± 3
3 h 99 ± 2 98 ± 2 99 ± 1.’’ 30 ± 3 33 ± 6 31 ± 4
4 h 99 ± 1 96 ± 2 99 ± 1.’’ 30 ± 3 33 ± 7 32 ± 4
1 h post op. 99 ± 1 98 ± 1 98 ± 1 32 ± 2 34 ± 1 35 ± 1#
GI = Sevoﬂurane–fentanyl group, GII = propofol–fentanyl group, GIII = dexmedetomidine–fentanyl group.
\ Signiﬁcant difference between GI and GII (P< 0.05).
 Intra group signiﬁcant difference as related to basal (P< 0.05).
# Signiﬁcant difference between GI and GIII (P< 0.05).
‘‘ Signiﬁcant difference between GII and GIII (P< 0.05).
Table 3 Intubation conditions and responses. Values are in numbers (%).
Airway conditions and intubating responses Score GI (n= 20) GII (n= 20) GII (n= 20) P value
Jaw relaxation
Fully relaxed 1 11 (55.0%) 14 (70.0%) 14 (70.0%) 0.395
Mild resistance 2 6 (30.0%) 5 (25.0%) 6 (30.0%)
Tight, but opens 3 3 (15.0%) 1 (5.0%) 0 (0%)
Impossible 4 0 (0%) 0 (0%) 0 (0%)
Vocal cord position
Widely open 1 6 (30.0%) 2 (10.0%) 7 (35.0%) 0.238
Mid-position 2 10 (50.0%) 11 (55.0%) 9 (45.0%)
Moving, but open 3 3 (15.0%) 5 (25.0%) 2 (10.0%)
Closed 4 1 (5.0%) 2 (10.0%) 2 (10.0%)
Intubating responses
None 1 13 (65.0%) 10 (50.0%) 14 (70.0%) 0.196
Diaphragmatic movement 2 5 (25.0%) 7 (35.0%) 3 (15.0%)
Mild/moderate coughing 3 2 (10.0%) 3 (15.0%) 2 (10.0%)
Severe coughing 4 0 (0%) 0 (0%) 1 (5.0%)
GI = sevoﬂurane–fentanyl group, GII = propofol–fentanyl group, GIII = dexmedetomidine–fentanyl group.
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during operative period (Table 2).
Tracheal intubation was successful in all patients. Jaw
relaxation, vocal cord position and intubating responses were
similar in the three groups (Table 3).
Intubation scores showed no signiﬁcant differences between
the studied groups (Table 4).
Visual analogue scale score (VAS) showed no signiﬁcant
difference between propofol–fentanyl group and dexmedetom-
idine–fentanyl group throughout the 24 h postoperatively.
Whereas both groups displayed signiﬁcant lower VAS than
sevoﬂurane–fentanyl group throughout the 24 h postopera-
tively (P< 0.001)(Fig. 2).
Respiratory rate values (RR) in the dexmedetomidine–fen-
tanyl group were signiﬁcantly increased (P< 0.05) compared
with baseline value at 35 min postoperatively. RR valued in
the dexmedetomidine–fentanyl group displayed signiﬁcant in-crease than those in the other two groups (P< 0.05) at 15,
25 and 35 min postoperatively (Fig. 3).
Sedation score was signiﬁcantly lower in sevoﬂurane–fenta-
nyl group than propofol–fentanyl group throughout the re-
corded postoperative hours. Noticeably, all readings of
sedation score in dexmedetomidine–fentanyl group were sig-
niﬁcantly higher than both other groups (Fig. 4).
Forty-ﬁve percent of the total number of the patients in the
propofol–fentanyl group developed nausea and shivering
which was signiﬁcantly higher in compared with other two
groups (P ranged from< 0.01 to < 0.001) (Fig. 5).
4. Discussion
In the present study, the three groups; sevoﬂurane–fentanyl,
propofol–fentanyl and dexmedetomidine–fentanyl were com-
pared as regard hemodynamics, intubation conditions, seda-
Table 4 Intubation score. Values are in numbers (%).
GI (n= 20) GII (n= 20) GIII (n= 20) P value
Excellent (3) 5 (25%) 5 (25%) 7 (33.75%) 0.394
Good (4–6) 10 (50%) 12 (60%) 12 (60%) 0.388
Poor (7–9) 4 (18%) 2 (8.75%) 1 (6.25%) 0.219
Impossible (10–12) 1 (6.25%) 1 (6.25%) 0 (0%) 0.932
GI = sevoﬂurane–fentanyl group, GII = propofol–fentanyl group, GIII = dexmedetomidine–fentanyl group.
36 S.A. Mousa, H. Abd Elfatah Alsobkytion score, postoperative pain and any postoperative complica-
tions. Patients in all groups demonstrated comparable both
demographic characteristics and hemodynamics. Also, dex-
medetomidine–fentanyl group displayed signiﬁcant increase
in arterial oxygen saturation at 1, 2 and 4 h intraoperatively
compared with propofol–fentanyl group, whereas it demon-
strated a signiﬁcant increase in EtCO2 one hour postopera-
tively compared with sevoﬂurane–fentanyl group.
Sevoﬂurane–fentanyl group demonstrated signiﬁcant higher
VAS than other two groups.
Anesthesia for patients with brachial plexus injury should
provide safety for these patients primarily by anticipating
and preventing situations which risk their deterioration in both
sensory and motor ability. Based on this concept, general anes-
thesia was selected as an anesthetic method in the current
study.
In the current study HR and MBP showed no signiﬁcant
changes among the studied groups throughout the study peri-
od. HR and MBP displayed signiﬁcant reduction in the three
groups compared with baseline values. The same results were
reported by Kaygusuz et al. [12] those underwent their study
on 46 patients allocated into two groups received either dex-
medetomidine or propofol for elective shockwave lithotripsy.
Previous investigations had demonstrated a powerful inhibi-
tory effect of propofol on sympathetic outﬂow [13]. It was
established that, dexmedetomidine also known to decreases
sympathetic outﬂow and circulating catecholamine levels and
therefore be expected to cause decrease of MBP similar to pro-
pofol [14]. Other studies have shown a greater decrease inVAS
0
1
2
3
4
5
6
7
VAS Early
po
15 min 30 min 1 hr 2 hr
GP 1
GP 2
GP 3
* 
*
Figure 2 Visual analogue scale (VAS) of the studied groups. Values
other two groups. GI = sevoﬂurane–fentanyl group, GII = propofol–MBP after induction of anesthesia with propofol than with
sevoﬂurane [15]. It was documented that, a bolus injection of
propofol could produce a 15–30% reduction in MBP [16].
Watson and Shah found a similar decrease in MBP with pro-
pofol and sevoﬂurane just before intubation [17]. This could be
assumed largely to the fact that both agents decrease systemic
vascular resistance through endothelium mediated vasodila-
tion [18], which is further augmented when administered with
an opioid [16].
In the current study, propofol–fentanyl group and dex-
medetomidine–fentanyl group were equally effective with re-
spect to pain control (VAS), with signiﬁcant lower score
compared with sevoﬂurane–fentanyl group throughout the
postoperative 24 h. This result was in accordance with previ-
ous study that found the recovery of patients induced and
maintained with sevoﬂurane were accompanied with restless
or agitation upon awakening than those induced with propofol
group, which was seen in the higher scores for pain in the
recovery room and the increased incidence of emergence delir-
ium and the high score of pain would account for the earlier
administration of analgesics to the patients in the sevoﬂurane
group [19].
In previous studies in children, awakening from sevoﬂurane
anesthesia has been associated with discomfort, excitement or
agitation, the mechanism of which is still unclear [20]. In our
study, pain may have been a contributing factor. In an anec-
dotal reports describe the efﬁcacy and the effect of dexmede-
tomidine versus propofol during intraoperative sedation,
proved that dexmedetomidine had signiﬁcantly reduced pain4 hr 6 hr 12 hr 18 hr 24 hr
*
*
*
*
*
are presented as mean ± SD. \Statistically signiﬁcant compared to
fentanyl group, GIII = dexmedetomidine–fentanyl group.
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Figure 3 Respiratory rate of the studied groups. = Intra group signiﬁcant difference as related to basal (P< 0.05). # = Signiﬁcant
difference between GI and GIII (P< 0.05). ‘‘ = Signiﬁcant difference between GII and GIII (P< 0.05). GI = sevoﬂurane–fentanyl
group, GII = propofol–fentanyl group, GIII = dexmedetomidine–fentanyl group.
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Figure 4 Sedation score of the studied groups. \ Signiﬁcant difference between GI and GII (P< 0.05). # = Signiﬁcant difference
between GI and GIII (P< 0.05). ‘‘ = Signiﬁcant difference between GII and GIII (P< 0.05). GI = sevoﬂurane–fentanyl group,
GII = propofol–fentanyl group, GIII = dexmedetomidine–fentanyl group.
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better analgesic properties of the dexmedetomidine than pro-
pofol (lower VAS) which was not relevant clinically as both
groups had VAS scores <4 [22]. It is now well described that
dexmedetomidine has analgesia sparing components when
used for sedation in the intensive care unit [23].
In the current study, respiratory rate (RR) and SpaO2 dis-
played signiﬁcant increase in dexmedetomidine–fentanyl group
compared with the other two groups for RR and with propo-
fol–fentanyl group only for SpaO2, which pass in accordance
with Ghali et al. on their study of conscious sedation during
vitreoretinal surgery [22]. Hsu et al. reported similar effectson respiratory functions during dexmedetomidine sedation
[24]. This might be explained by the increase in minute
ventilation postoperatively coincided with the signiﬁcant
postoperative increase of CO2 that observed with dexmede-
tomidine–fentanyl group leading to the arousal phenomenon
secondary to the hypercapnia stimulation. In addition, it was
reported that a-2 receptors are located at multiple places in
the central nervous system. Hypercarpia activates the locus
ceruleus, which is associated with increase apprehension which
leads to the stimulation of the respiratory centers [25].
On the other hand, previous study conﬁrmed a lack of a clin-
ically signiﬁcant respiratory effect of dexmedetomidine [26].
Table 5 Modiﬁed Aldrete’s score.
Score
Level of consciousness
Awake and oriented 2
Arousable with minimal stimulation 1
Responsive only to tactile stimulation 0
Physical activity
Able to move all extremities on command 2
Some weakness in movement of extremities 1
Unable to voluntarily move extremities 0
Hemodynamic stability
Blood pressure ,15% of baseline MAP value 2
Blood pressure 15–30% of baseline MAP value 1
Blood pressure .30% below baseline MAP value 0
Respiratory stability
Able to breathe deeply 2
Tachypnea with good coughs 1
Dyspneic with weak cough 0
Oxygen saturation status
Maintains value .90% on room air 2
Requires supplemental oxygen (nasal prongs) 1
Saturation ,90% with supplemental oxygen 0
Postoperative pain assessment
None or mild discomfort 2
Moderate to severe pain controlled with IV analgesics 1
Persistent severe pain 0
Postoperative emetic symptoms
None or mild nausea with no active vomiting 2
Transient vomiting or retching 1
Persistent moderate to severe nausea and vomiting 0
Total score 14
MAP=mean arterial pressure.
Score P10 was needed for PACU discharge.
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Figure 5 Postoperative complications of the studied groups.
Values are presented as percentage of the patients. \ Statistically
signiﬁcant compared to the other two groups. GI = sevoﬂurane–
fentanyl group, GII = propofol–fentanyl group, GIII = dex-
medetomidine–fentanyl group.
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been greatly debated, but the consensus appears to be that
dexmedetomidine is associated with little respiratory depres-
sion [27].
There was signiﬁcant increase in sedation score throughout
the postoperative period in dexmedetomidine–fentanyl group
compared with other both groups, which might be attributed
to the drug regimen (induction and maintenance) of dexmede-
tomidine as well as the augmenting effect of concomitant infu-
sion of fentanyl with dexmedetomidine. On the other hand,
Arain and Ebert in their study on intraoperative sedation using
dexmedetomidine versus propofol proved that all patients in
both groups achieved targeted sedation levels; however, pa-
tients receiving propofol for sedation achieved levels of seda-
tion more rapidly than those receiving dexmedetomidine [21].
In another study, it was proved that dexmedetomidine
group showed signiﬁcant lower Observer’s Assessment of
Alertness/Sedation Scores (OAA/S score) than propofol group
in patients underwent shockwave lithotripsy and it was ob-
served that the OAA/S score values at 5–35 min. were signiﬁ-
cantly lower than those at baseline in both the
dexmedetomidine and propofol groups [12].
Other interesting study on clinical comparison of single
agent anesthesia with sevoﬂurane versus target controlled infu-
sion of propofol, sedation was assessed by measuring time
intervals between discontinuation of drugs and eye opening,
extubation and stating name and date of birth for each pa-
tients. It was proved that, all these times were similar in both
groups and there were no differences in subsequent recovery
events [17].
Tracheal intubation was successful in all patients. Jaw
relaxation, vocal cord position and intubating responses were
similar in the three groups indicating that the use of this com-
bination of the drugs could be effective for intubation in such
group of patients. In the current study, sevoﬂurane–fentanyl
group showed 25% of patients had excellent and 50% of pa-
tients had good intubating conditions. Thus 75% of patients
had clinically acceptable intubating conditions. Whereas, in
propofol–fentanyl and dexmedetomidine–fentanyl groups
85% and 93% of patients had clinically acceptable intubating
conditions respectively. There were no previous studies discuss
the comparison between these three groups of drugs as regardthe intubation conditions, but there were a lot of studies that
discussed the intubation conditions with varying doses of pro-
pofol without muscle relaxants. In one of these studies, it was
proved that, ideal intubating conditions without using muscle
relaxants are possible with 3 mg kg1 propofol with 2 lg kg1
fentanyl and 1.5 mg kg1 lignocaine and the stress response to
laryngoscopy and intubation gets attenuated well [28].
In other study, that did not use muscle relaxant for intuba-
tion, authors concluded that endotracheal intubation was
better with the dexmedetomidine–lidocaine–propofol combi-
nation than with the fentanyl–lidocaine–propofol combina-
tion. However, side effects such as bradycardia should be
considered when using dexmedetomidine. This pass in accor-
dance with our result that proved dexmedetomidine–fentanyl
had acceptable intubation conditions [29].
Sevoﬂurane 8% can be as satisfactory as neuromuscular
blocking drugs for producing the necessary conditions for intu-
bating the trachea, but cannot achieve the speed of onset of ef-
fect for rapid sequence intubation and it has a lower blood gas
solubility and less likely to cause cardiac depression or
arrhythmias than halothane. This has made it an attractive
alternative for use in the difﬁcult airway [30]. A potential lim-
itation of the inhaled induction technique for tracheal intuba-
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tration of sevoﬂurane [31].
Postoperative complications were more signiﬁcant with
propofol–fentanyl group (nausea and shivering) which might
be attributed to the signiﬁcant hypotension that could be
occurred in more pronounced manner in propofol–fentanyl
group compared with basal values. Watson and Shah observed
the occurrence of nausea and vomiting in their comparative
study between sevoﬂurane and target controlled infusion of
propofol [17].
There is strong evidence to suggest that propofol has intrin-
sic anti emetic properties that may persist into the postopera-
tive period even when it is used solely as an induction agents
[32]. With an equipotent dose of dexmedetomidine used in
our study, Kaygusuz et al. found no differences in the inci-
dence of postoperative nausea and vomiting between dexmede-
tomidine and propofol used in their study [12].
The current study has certain limitations which includes,
the double blinding can not be achieved. The increasing pat-
tern of visual analogue scale with all groups, indicating insuf-
ﬁcient analgesia. Although the dose of fentanyl used is lower
than its standard use, our data suggest that this combination
of dexmedetomidine–fentanyl or propofol–fentanyl provides
better pain relief during repair of brachial plexus injury than
in sevoﬂurane–fentanyl group.
5. Conclusion
In conclusion, the three groups demonstrated equivalent
hemodynamic effect. Although infusion of sevoﬂurane, propo-
fol and dexmedetomidine anesthesia provided safe and ade-
quate induction and maintenance of anesthesia in the repair
of brachial plexus injury procedure, analgesia and respiratory
variables were better with propofol than either dexmedetomi-
dine or sevoﬂurane. Further studies are needed to determine
the optimal pain control for this group of patients for long
time postoperatively.Financial support
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